Stocktoria

Innoviva, Inc. INVA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2004-10-05 · LEI

Innoviva, Inc. financials (annual)

Revenue
$133.6M $217.2M $261.0M $261.0M $336.8M $391.9M $331.3M $310.5M $358.7M $411.3M 2016201720182019202020212022202320242025
Net income
2016201720182019202020212022202320242025
Free cash flow
$60.7M $141.7M $223.5M $257.4M $313.1M $363.8M $201.7M $140.7M $188.4M $195.8M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$411.3M$358.7M$310.5M$331.3M$391.9M$336.8M$261.0M$261.0M$217.2M$133.6M
Gross profit$307.7M$296.2M$246.0M
R&D expense$30.6M$13.7M$33.9M$41.4M$576,000$1.8M$0$0$1.4M$1.4M
SG&A expense$113.3M$115.7M$98.2M$63.5M$16.2M$13.9M
Operating income$163.7M$166.9M$113.9M$375.1M$321.1M$246.4M$238.3M$183.6M$109.0M
Interest expense$16.7M$22.2M$19.2M$15.8M$19.1M$18.3M$18.7M$24.0M$43.6M$52.4M
Income tax$55.7M$14.0M$14.4M$66.7M$76.4M$60.4M$41.9M-$196.1M$4,000$95,000
Operating cash flow$196.9M$188.7M$141.1M$201.7M$363.8M$313.1M$257.5M$223.5M$141.7M$61.0M
Free cash flow$195.8M$188.4M$140.7M$201.7M$363.8M$313.1M$257.4M$223.5M$141.7M$60.7M
Cash & equivalents$550.9M$305.0M$193.5M$291.0M$201.5M$246.5M$278.1M$62.4M$73.3M$118.0M
Inventory$39.2M$33.7M$40.7M$55.9M$0
Total assets$1.6B$1.3B$1.2B$1.2B$926.4M$999.6M$724.8M$548.2M$367.3M$379.0M
Shareholders' equity$1.2B$691.2M$675.0M$565.8M$525.9M$607.8M$342.1M$159.1M-$242.9M-$353.0M
EPS (diluted)$3.30$0.36$2.20$2.37$2.87$2.02$1.43$3.53$1.17$0.53

Growth · year-over-year · Revenue CAGR 13.3%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+14.7%+15.5%-6.3%-15.4%+16.4%+29.0%+0.0%+20.2%+62.6%+147.6%
EPS growth+816.7%-83.6%-7.2%-17.4%+42.1%+41.3%-59.5%+201.7%+120.8%
Free cash flow growth+3.9%+34.0%-30.3%-44.6%+16.2%+21.6%+15.2%+57.7%+133.5%+499.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.